SCHEMBL31265130

SCHEMBL31265130

CCOC(=O)Nc1nc2cc(OC)ccc2[nH]1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.53
MAPK1 P28482 1/20 0.53
HIF1A Q16665 1/20 0.53
KCNQ2 O43526 1/20 0.53
KMT2A Q03164 7/20 0.52
MEN1 O00255 6/20 0.52
ALDH1A1 P00352 4/20 0.52
HSD17B10 Q99714 2/20 0.52
ALOX15 P16050 1/20 0.52
RAB9A P51151 8/20 0.50
NPC1 O15118 7/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
MAPT P10636 3/20 0.50
KDM4E B2RXH2 3/20 0.50
PKM P14618 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
HPGD P15428 2/20 0.50
HTT P42858 2/20 0.50
TUBB4A P04350 2/20 0.50
TUBB P07437 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14097387 0.91 KCNQ2 (0.57) LMNAMAPK1HIF1AKCNQ2KMT2A
SCHEMBL11104041 0.90 LMNA (0.56) LMNAMAPK1HIF1AKCNQ2KMT2A
SCHEMBL31265132 0.88 TUBB4A (0.61) LMNAMAPK1HIF1AKMT2AMEN1
SCHEMBL14097391 0.87 KCNQ2 (0.49) LMNAMAPK1HIF1AKCNQ2KMT2A
SCHEMBL11096138 0.86 TUBB4A (0.48) LMNAMAPK1HIF1AKMT2AMEN1
SCHEMBL14097446 0.86 TUBB4A (0.50) LMNAMAPK1HIF1AKCNQ2KMT2A
SCHEMBL31265123 0.84 KDM4E (0.51) LMNAMAPK1HIF1AKMT2AMEN1
SCHEMBL31265133 0.83 KDM4E (0.53) LMNAMAPK1HIF1AALDH1A1ALOX15
SCHEMBL14097390 0.82 SMN1; SMN2 (0.54) LMNAMAPK1HIF1AKCNQ2KMT2A
SCHEMBL11809362 0.81 LMNA (0.51) LMNAMAPK1HIF1AKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024249488-A2 INHIBITORS OF DYRK1A BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) 2024-12-05 WO disclosed